CJC 1295 DAC

Price range: $99.99 through $399.99
1
Lab Tested
Third-party verified
Ships Fast
1-2 business days
Research Use Only
This product is intended for laboratory research purposes only. Not for human or animal consumption.

Description

CJC-1295 DAC is a synthetic tetrasubstituted peptide analog supplied as a high-purity lyophilized powder, incorporating Drug Affinity Complex (DAC) technology for extended stability in controlled research environments. The modified structure includes specific amino acid substitutions and a reactive group enabling covalent binding characteristics, and is manufactured under stringent conditions with validated analytical confirmation of identity, purity, and batch consistency. For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.

Storage: Lyophilized material should be stored refrigerated (2–8°C), protected from light. After reconstitution, store refrigerated (2–8°C) and use within a limited research window under appropriate laboratory handling conditions.

Lab Results (COA)

Every batch is tested by an independent third-party laboratory. Download the Certificate of Analysis for complete purity and composition data.

Batch Number: BATCH-2024001
Test Date: Jan 15, 2024
Purity: 99.2%

Properties

CAS Number 863288-34-0
Synonyms CJC-1295 with DAC; GRF(1-29) DAC; Modified GRF 1-29 DAC
Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys-NH2 (modified with DAC)
Molecular Formula C152H252N44O42
Molecular Weight 3367.93
Physical Appearance White to off-white lyophilized powder
Terms Laboratory research use only (Ascend Peptides). Not for human, animal, diagnostic, or household use.

2D Structure

Structural representation for reference only

Restricted Access: Research Use Only

Ascend Peptides provides materials for laboratory research purposes only. Before entering this website, you must confirm that you understand and agree to the research-use-only restrictions below.